InvestorsHub Logo

Whalatane

06/02/19 11:45 AM

#194699 RE: couldbebetter #194693

CBB ...name one compound that "looks promising " with the safety profile of Vascepa ?.....

As mentioned in the previous post . A lot can be gained from a retrospective analysis of those who were in R-IT.
Are there other the long term benefits of 4 gms of V ...besides the RRR of Mi's and strokes....?

They have a data base of 4,000 ? CAD patients who were on statins and 4 gms of Vascepa to work with .

JMO
Kiwi

rosemountbomber

06/02/19 2:07 PM

#194719 RE: couldbebetter #194693

Could I agree and one of the major reasons is that I was invested in Elan during the whole bapineuzumab (sp?) trials for Alzheimer's (also Tysabri). Anyway the ups and downs with Elan has gotten me real gun-shy when it comes drugs to solve Alzheimer's.